PK of HCP1303 vs Co-administration of HGP1201 and HIP1402

Phase 1, randomised, open-label trial of tadalafil and tamsulosin in erectile dysfunction (ED) and benign prostatic hyperplasia (BPH) (2 arms), sponsored by Hanmi Pharmaceutical. Primary endpoints: Area Under the Concentration-Time Curve from Time Zero to Last Quantifiable Concentration at 72 hours and Maximum Plasma Concentration at 72 hours. Started Jul 2015; status: completed.